The Functional Property Changes of Muscular Na(v)1.4 and Cardiac Na(v)1.5 Induced by Scorpion Toxin BmK AGP-SYPU1 Mutants Y42F and Y5F.

Scorpion toxins are invaluable therapeutic leads and pharmacological tools which influence the voltage-gated sodium channels. However, the details were still unclear about the structure-function relationship of scorpion toxins on VGSC subtypes. In the previous study, we reported one α-type scorpion toxin Bmk AGP-SYPU1 and its two mutants (Y5F and Y42F) which had been demonstrated to ease pain in mice acetic acid writhing test. However, the function of Bmk AGP-SYPU1 on VGSCs is still unknown. In this study, we examined the effects of BmK AGP-SYPU1 and its two mutants (Y5F and Y42F) on hNa(v)1.4 and hNa(v)1.5 heterologously expressed CHO cell lines by using Na⁺-specialized fluorescent dye and whole-cell patch clamp. The data showed that BmK AGP-SYPU1 displayed as an activator of hNa(v)1.4 and hNa(v)1.5, which might indeed contribute to its biotoxicity to muscular and cardiac system and exhibited the functional properties of both the α-type and β-type scorpion toxin. Notably, Y5F mutant exhibited lower activatory effects on hNa(v)1.4 and hNa(v)1.5 compared with BmK AGP-SYPU1. Y42F was an enhanced activator and confirmed that the conserved Tyr42 was the key amino acid involved in bioactivity or biotoxicity. These data provided a deep insight into the structure-function relationship of BmK AGP-SYPU1, which may be the guidance for engineering α-toxin with high selectivity on VGSC subtypes.

[1]  Chunfu Wu,et al.  Location of the analgesic domain in Scorpion toxin BmK AGAP by mutagenesis of disulfide bridges. , 2010, Biochemical and biophysical research communications.

[2]  Yong-hua Ji,et al.  U‐shaped dose‐dependent effects of BmK AS, a unique scorpion polypeptide toxin, on voltage‐gated sodium channels , 2009, British journal of pharmacology.

[3]  J. Tytgat,et al.  Roles of disulfide bridges in scorpion toxin BmK M1 analyzed by mutagenesis. , 2002, The journal of peptide research : official journal of the American Peptide Society.

[4]  J. Tytgat,et al.  Voltage-gated sodium channel modulation by scorpion alpha-toxins. , 2007, Toxicon : official journal of the International Society on Toxinology.

[5]  S. Heinemann,et al.  Interaction of Scorpion α-Toxins with Cardiac Sodium Channels , 2001, The Journal of General Physiology.

[6]  S. Priori,et al.  Gating Properties of SCN5A Mutations and the Response to Mexiletine in Long-QT Syndrome Type 3 Patients , 2007, Circulation.

[7]  Yu Wang,et al.  Purification, characterization and functional expression of a new peptide with an analgesic effect from Chinese scorpion Buthus martensii Karsch (BmK AGP-SYPU1). , 2011, Biomedical chromatography : BMC.

[8]  W. Catterall.  Sodium channels, inherited epilepsy, and antiepileptic drugs. , 2014, Annual review of pharmacology and toxicology.

[9]  C. Granier,et al.  Structure/activity relationships of scorpion alpha-toxins. Multiple residues contribute to the interaction with receptors. , 1989, European journal of biochemistry.

[10]  I. Vetter,et al.  Chemical engineering and structural and pharmacological characterization of the α-scorpion toxin OD1. , 2013, ACS chemical biology.

[11]  Silvia G. Priori,et al.  Sodium channel mutations and arrhythmias , 2009, Nature Reviews Cardiology.

[12]  S. Cannon.  An expanding view for the molecular basis of familial periodic paralysis , 2002, Neuromuscular Disorders.

[13]  Jan Tytgat,et al.  Importance of the conserved aromatic residues in the scorpion alpha-like toxin BmK M1: the hydrophobic surface region revisited. , 2003, The Journal of biological chemistry.

[14]  Alfred L George,et al.  Inherited disorders of voltage-gated sodium channels. , 2005, The Journal of clinical investigation.

[15]  Yong-hua Ji,et al.  The modulation effects of BmK I, an α-like scorpion neurotoxin, on voltage-gated Na+ currents in rat dorsal root ganglion neurons , 2005, Neuroscience Letters.

[16]  Clifford J. Woolf,et al.  Nociceptors—Noxious Stimulus Detectors , 2007, Neuron.

[17]  Li Deng,et al.  Site-Directed Mutagenesis of BmK AGP-SYPU1: The Role of Two Conserved Tyr (Tyr5 and Tyr42) in Analgesic Activity , 2014, The Protein Journal.

[18]  Chunfu Wu,et al.  AGAP, a new recombinant neurotoxic polypeptide, targets the voltage-gated calcium channels in rat small diameter DRG neurons. , 2014, Biochemical and biophysical research communications.

[19]  M. Cárdenas,et al.  Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: a case series and literature review. , 2012, Heart rhythm.

[20]  A. George,et al.  Ranolazine selectively blocks persistent current evoked by epilepsy‐associated NaV1.1 mutations , 2010, British journal of pharmacology.

[21]  H. Rochat,et al.  Characterization of toxin III of the scorpion Leiurus quinquestriatus quinquestriatus: a new type of alpha-toxin highly toxic both to mammals and insects. , 1993, Natural toxins.

[22]  D. Gros,et al.  Mouse Model of SCN5A-Linked Hereditary Lenègre’s Disease: Age-Related Conduction Slowing and Myocardial Fibrosis , 2005, Circulation.

[23]  Z. Zeng,et al.  Crystal structures of two alpha-like scorpion toxins: non-proline cis peptide bonds and implications for new binding site selectivity on the sodium channel. , 1999, Journal of molecular biology.

[24]  W. Catterall,et al.  Voltage-gated ion channels and gating modifier toxins. , 2007, Toxicon : official journal of the International Society on Toxinology.

[25]  Oren Froy,et al.  Molecular Basis of the High Insecticidal Potency of Scorpion α-Toxins* , 2004, Journal of Biological Chemistry.

[26]  C. Granier,et al.  An anti-insect toxin purified from the scorpion Androctonus australis Hector also acts on the alpha- and beta-sites of the mammalian sodium channel: sequence and circular dichroism study. , 1991, Biochemistry.

[27]  W. Catterall,et al.  Molecular Requirements for Recognition of Brain Voltage-gated Sodium Channels by Scorpion α-Toxins* , 2009, The Journal of Biological Chemistry.

[28]  G. Breithardt,et al.  Genetic basis and molecular mechanism for idiopathic ventricular fibrillation , 1998, Nature.

[29]  W. Gerwick,et al.  Influence of Lipid-Soluble Gating Modifier Toxins on Sodium Influx in Neocortical Neurons , 2008, Journal of Pharmacology and Experimental Therapeutics.

[30]  Y. Ji,et al.  Biosensor binding assay of BmK AS-1, a novel Na+ channel-blocking scorpion ligand on rat brain synaptosomes. , 1999, Neuroreport.

[31]  Michael Christiansen,et al.  The genetic basis of Brugada syndrome: A mutation update , 2009, Human mutation.

[32]  Arthur J Moss,et al.  SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome , 1995, Cell.

[33]  F. Lehmann-Horn,et al.  Human muscle voltage-gated ion channels and hereditary disease. , 2001, Current opinion in pharmacology.

[34]  W. Catterall,et al.  Reconstitution of High‐Affinity Binding of a β‐Scorpion Toxin to Neurotoxin Receptor Site 4 on Purified Sodium Channels , 1995, Journal of neurochemistry.

[35]  M. Gurevitz.  Mapping of scorpion toxin receptor sites at voltage-gated sodium channels. , 2012, Toxicon : official journal of the International Society on Toxinology.